Hero Image
Zenrelia
Zenrelia (Ilunocitinib Tablet) | Once Daily Prescription Itch Relief for Dogs | 15 mg (90 Count)
Elanco Item # CA5539090AM Product Title Zenrelia (Ilunocitinib Tablet) | Once Daily Prescription Itch Relief for Dogs | 15 mg (90 Count) Product Class Rx Each - UPC 00727804002145 Brand Zenrelia Item Name Zenrelia for Dogs 15 mg - 90 Tablets Country of Origin Germany Long Description Allergic dermatitis can make your dog very uncomfortable. Symptoms like excessive itching, scratching, and biting aren't only disruptive to you and your pet, but they can also cause more severe problems over time, including hair loss and skin infection. Zenrelia (ilunocitinib tablets) is a once-daily tablet that relieves itching due to allergic dermatitis and controls atopic dermatitis. Zenrelia is designed to begin working rapidly.* The active ingredient, ilunocitinib, reduces the inflammatory response in your dog's skin caused by allergies, making your dog feel less itchy. What's more, Zenrelia is designed to deliver continuous efficacy over the long term and can get your dog back to normal**. Dogs should not take Zenrelia for at least 28 days to 3 months prior to vaccination and should not take Zenrelia for at least 28 days after vaccination. Discuss your dog’s vaccine schedule with your veterinarian. Zenrelia is given once a day with or without food, so it may be easier to incorporate into your daily routine. Always follow your veterinarian's instructions. The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert including the Boxed Warning. Zenrelia is a prescription itch relief medication for dogs at least 12 months of age. Ask your veterinarian if Zenrelia can relieve itching in your dog due to allergic and atopic dermatitis. Fast relief for your best friend is also a relief for you. Spend more time doing the things you love, like cuddling and playing, and less time managing your dog's allergy symptoms. * Forster S, Boegel A, Despa S, et al. Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Veterinary Dermatology. 2025; 1–10 ** Clinical remission of itch demonstrated by a Normal-PVAS<2 Medium Description Zenrelia (ilunocitinib tablets) is a prescription itch relief medication for dogs that relieves itching due to allergic dermatitis and controls atopic dermatitis. The active ingredient, ilunocitinib, reduces the inflammatory response in your dog's skin caused by allergies, making them feel less itchy. What's more, Zenrelia is designed to deliver continuous efficacy over the long term and can get your dog back to normal**. Dogs should not take Zenrelia for at least 28 days to 3 months prior to vaccination and should not take Zenrelia for at least 28 days after vaccination. Discuss your dog’s vaccine schedule with your veterinarian. **Clinical remission of itch demonstrated by a Normal-PVAS<2 Short Description Zenrelia (ilunocitinib tablets) is a prescription itch relief medication for dogs that relieves itching due to allergic dermatitis and controls atopic dermatitis. The active ingredient, ilunocitinib, reduces the inflammatory response in your dog's skin caused by allergies, making them feel less itchy. What's more, Zenrelia is designed to deliver continuous efficacy over the long term and can get your dog back to normal**. Dogs should not take Zenrelia for at least 28 days to 3 months prior to vaccination and should not take Zenrelia for at least 28 days after vaccination. Discuss your dog’s vaccine schedule with your veterinarian. **Clinical remission of itch demonstrated by a Normal-PVAS<2 Key Bullet 1 Zenrelia relieves itching in dogs due to allergic dermatitis and controls atopic dermatitis Key Bullet 2 Zenrelia works fast, providing visible improvements in itch* * Forster S, Boegel A, Despa S, et al. Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Veterinary Dermatology. 2025; 1–10 Key Bullet 3 Ilunocitinib, the active ingredient in Zenrelia, works by reducing the itch and inflammatory response in your dog's skin due to allergies Key Bullet 4 The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert including the Boxed Warning Key Bullet 5 The once-daily tablet can be given with or without food from the comfort of your home Species Dog Directions for Use Once daily, oral tablet for the control of itch associated with allergic and atopic dermatitis, in dogs 12 months and up. Storage Instructions Store at room temperature between 15-25 C (59 to 77 F) Active Ingredients ilunocitinib Product Form Tablet Product Label URL http://www.elancolabels.com/us/zenrelia Clamshelled Version? No Dimensions UoM in Weight UoM lb Master Case - Height 8.5 Master Case - Length 12.75 Master Case - Width 8.9 Master Case - Weight 9.67